Beacon Therapeutics is an ophthalmic gene therapy company that restores and improves vision and rare retinal diseases that result in blindness.

Health Care

Life Sciences

Therapeutics

Beacon Therapeutics

Beacon Therapeutics' headquarters in Alachua, FL, United States

David Fellows

Nadia Waheed

Daniel C. Chung

Xuandai Nguyen

Martin Quinn

Bryce Lay

Donna Burch

Petra Marks

Amy Adelman House

Ben Rigby

Abraham Scaria

This department focuses on overseeing and advancing clinical development processes and quality assurance in research and development.

Clinical Development

This department oversees the strategic direction and operational management of medical activities, including regulatory compliance and communication.

Medical Affairs

This department focuses on the application of statistical methods to analyze biological data and support clinical trials.

Biostatistics Department

This department oversees the activities and duties of the board, ensuring compliance and effective governance.

Board Governance

This department provides strategic direction and governance for the organization.

Executive Leadership

The Research and Development team at Beacon Therapeutics is dedicated to advancing innovative gene therapies aimed at treating rare retinal diseases. This team, comprised of scientists and medical affairs experts, conducts cutting-edge research, develops experimental therapies, and performs rigorous clinical evaluations to ensure safety and efficacy. Their collaborative efforts are crucial to the company's mission of restoring and improving vision for individuals affected by these debilitating conditions.

Beacon Therapeutics

Org chart

Teams

Clinical Development

Medical Affairs

Biostatistics Department

Board Governance

Executive Leadership

Research and Development

Offices

Beacon Therapeutics

Org chart

Teams

Clinical Development

Medical Affairs

Biostatistics Department

Board Governance

Executive Leadership

Research and Development

Offices

Related companies